• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中数量与肿瘤CD274(PD-L1)表达之间的负相关关系。

Inverse relationship between amount and tumor CD274 (PD-L1) expression in colorectal carcinoma.

作者信息

Ugai Tomotaka, Shimizu Takashi, Kawamura Hidetaka, Ugai Satoko, Takashima Yasutoshi, Usui Genki, Väyrynen Juha P, Okadome Kazuo, Haruki Koichiro, Akimoto Naohiko, Masugi Yohei, da Silva Annacarolina, Mima Kosuke, Zhang Xuehong, Chan Andrew T, Wang Molin, Garrett Wendy S, Freeman Gordon J, Meyerhardt Jeffrey A, Nowak Jonathan A, Song Mingyang, Giannakis Marios, Ogino Shuji

机构信息

Program in MPE Molecular Pathological Epidemiology, Department of Pathology Brigham and Women's Hospital and Harvard Medical School Boston MA USA.

Department of Epidemiology Harvard T.H. Chan School of Public Health Boston MA USA.

出版信息

Clin Transl Immunology. 2023 Aug 2;12(8):e1453. doi: 10.1002/cti2.1453. eCollection 2023.

DOI:10.1002/cti2.1453
PMID:
37538192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10394676/
Abstract

OBJECTIVES

The CD274 (programmed cell death 1 ligand 1, PD-L1)/PDCD1 (programmed cell death 1, PD-1) immune checkpoint axis is known to regulate the antitumor immune response. Evidence also supports an immunosuppressive effect of . We hypothesised that tumor CD274 overexpression might be inversely associated with abundance of in colorectal carcinoma.

METHODS

We assessed tumor CD274 expression by immunohistochemistry and DNA within tumor tissue by quantitative PCR in 812 cases among 4465 incident rectal and colon cancer cases that had occurred in two prospective cohort studies. Multivariable logistic regression analyses with inverse probability weighting were used to adjust for selection bias because of tissue data availability and potential confounders including microsatellite instability status, CpG island methylator phenotype, LINE-1 methylation level and , and mutations.

RESULTS

DNA was detected in tumor tissue in 109 (13%) cases. Tumor CD274 expression level was inversely associated with the amount of in colorectal cancer tissue ( = 0.0077). For one category-unit increase in three ordinal categories (negative vs. low vs. high), multivariable-adjusted odds ratios (with 95% confidence interval) of the low, intermediate and high CD274 categories (vs. negative) were 0.78 (0.41-1.51), 0.64 (0.32-1.28) and 0.50 (0.25-0.99), respectively (  = 0.032).

CONCLUSIONS

Tumor CD274 expression level was inversely associated with the amount of in colorectal cancer tissue, suggesting that different immunosuppressive mechanisms (i.e. PDCD1 immune checkpoint activation and tumor enrichment) tend to be used by different tumor subgroups.

摘要

目的

已知CD274(程序性细胞死亡1配体1,PD-L1)/PDCD1(程序性细胞死亡1,PD-1)免疫检查点轴可调节抗肿瘤免疫反应。也有证据支持……的免疫抑制作用。我们假设在结直肠癌中肿瘤CD274过表达可能与……丰度呈负相关。

方法

在两项前瞻性队列研究中发生的4465例新发直肠癌和结肠癌病例中的812例中,我们通过免疫组织化学评估肿瘤CD274表达,并通过定量PCR评估肿瘤组织内的……DNA。由于组织数据可用性和潜在混杂因素(包括微卫星不稳定性状态、CpG岛甲基化表型、LINE-1甲基化水平以及……、……和……突变),使用具有逆概率加权的多变量逻辑回归分析来调整选择偏倚。

结果

在109例(13%)病例的肿瘤组织中检测到……DNA。肿瘤CD274表达水平与结直肠癌组织中的……量呈负相关(……=0.0077)。对于三个有序……类别(阴性vs.低vs.高)中一个类别单位的增加,低、中和高CD274类别(vs.阴性)的多变量调整优势比(95%置信区间)分别为0.78(0.41 - 1.51)、0.64(0.32 - 1.28)和0.50(0.25 - 0.99)(……=0.032)。

结论

肿瘤CD274表达水平与结直肠癌组织中的……量呈负相关,表明不同的肿瘤亚组倾向于使用不同的免疫抑制机制(即PDCD1免疫检查点激活和肿瘤……富集)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa4d/10394676/55f524e1e159/CTI2-12-e1453-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa4d/10394676/2c281e03a3ef/CTI2-12-e1453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa4d/10394676/55f524e1e159/CTI2-12-e1453-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa4d/10394676/2c281e03a3ef/CTI2-12-e1453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa4d/10394676/55f524e1e159/CTI2-12-e1453-g001.jpg

相似文献

1
Inverse relationship between amount and tumor CD274 (PD-L1) expression in colorectal carcinoma.结直肠癌中数量与肿瘤CD274(PD-L1)表达之间的负相关关系。
Clin Transl Immunology. 2023 Aug 2;12(8):e1453. doi: 10.1002/cti2.1453. eCollection 2023.
2
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.结直肠癌中的肿瘤CD274(PD-L1)表达与T细胞
Gut. 2017 Aug;66(8):1463-1473. doi: 10.1136/gutjnl-2016-311421. Epub 2016 May 5.
3
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.具核梭杆菌与结直肠癌中的 T 细胞
JAMA Oncol. 2015 Aug;1(5):653-61. doi: 10.1001/jamaoncol.2015.1377.
4
Association of mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma.结直肠癌中 突变和 PTEN 缺失与 CD274(PD-L1)表达的关系。
Oncoimmunology. 2021 Aug 2;10(1):1956173. doi: 10.1080/2162402X.2021.1956173. eCollection 2021.
5
Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.自噬状态与结直肠癌中具核梭杆菌数量的关系。
J Pathol. 2020 Apr;250(4):397-408. doi: 10.1002/path.5381. Epub 2020 Feb 3.
6
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.结直肠癌组织中的具核梭杆菌与患者预后
Gut. 2016 Dec;65(12):1973-1980. doi: 10.1136/gutjnl-2015-310101. Epub 2015 Aug 26.
7
in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.在结直肠癌中,肿瘤微卫星不稳定性状态对免疫反应的影响存在差异。
Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.
8
Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.根据肿瘤CD274(程序性细胞死亡1配体1)表达状态分析阿司匹林使用与结直肠癌生存情况
J Clin Oncol. 2017 Jun 1;35(16):1836-1844. doi: 10.1200/JCO.2016.70.7547. Epub 2017 Apr 13.
9
Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.肿瘤 PDCD1LG2(PD-L2)表达与结直肠癌的淋巴细胞反应。
Cancer Immunol Res. 2017 Nov;5(11):1046-1055. doi: 10.1158/2326-6066.CIR-17-0122. Epub 2017 Oct 16.
10
Association of with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment.与结直肠癌微环境中特定 T 细胞亚群的关联。
Clin Cancer Res. 2021 May 15;27(10):2816-2826. doi: 10.1158/1078-0432.CCR-20-4009. Epub 2021 Feb 25.

引用本文的文献

1
Advancements in understanding tumor-resident bacteria and their application in cancer therapy.肿瘤驻留细菌的认识进展及其在癌症治疗中的应用。
Mil Med Res. 2025 Jul 25;12(1):38. doi: 10.1186/s40779-025-00623-1.
2
Unraveling the Role of in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights.解析[具体内容]在结直肠癌中的作用:分子机制与致病见解 (注:原文中“of”后面缺少具体内容)
Cancers (Basel). 2025 Jan 23;17(3):368. doi: 10.3390/cancers17030368.
3
Mendelian Randomization Reveals Potential Causal Relationships Between DNA Damage Repair-Related Genes and Inflammatory Bowel Disease.

本文引用的文献

1
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.肿瘤内微生物群对癌症空间和细胞异质性的影响。
Nature. 2022 Nov;611(7937):810-817. doi: 10.1038/s41586-022-05435-0. Epub 2022 Nov 16.
2
Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer.具核梭杆菌通过 IFIT1 相关信号促进结直肠癌细胞增殖并上调 PD-L1 表达
Neoplasia. 2023 Jan;35:100850. doi: 10.1016/j.neo.2022.100850. Epub 2022 Nov 10.
3
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1).
孟德尔随机化揭示DNA损伤修复相关基因与炎症性肠病之间的潜在因果关系。
Biomedicines. 2025 Jan 19;13(1):231. doi: 10.3390/biomedicines13010231.
4
[Genetic drivers for inflammatory protein markers in colorectal cancer: a Mendelian randomization approach to clinical prognosis study].[结直肠癌炎症蛋白标志物的遗传驱动因素:临床预后研究的孟德尔随机化方法]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1361-1369. doi: 10.12122/j.issn.1673-4254.2024.07.16.
5
Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers.具核梭杆菌与食管胃交界部和胃癌患者生存及酸性环境的关系。
Br J Cancer. 2024 Sep;131(5):797-807. doi: 10.1038/s41416-024-02753-0. Epub 2024 Jul 12.
6
Appendectomy and Long-term Colorectal Cancer Incidence, Overall and by Tumor Fusobacterium nucleatum Status.阑尾切除术与长期结直肠癌发病率,总体情况及按具核梭杆菌肿瘤状态分类的情况
Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006315.
梭杆菌属在口腔癌中富集,并促进程序性死亡配体 1(PD-L1)的诱导。
Neoplasia. 2022 Sep;31:100813. doi: 10.1016/j.neo.2022.100813. Epub 2022 Jul 11.
4
Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science.癌症作为微环境、全身性和环境性疾病:跨学科微生物组学的机遇。
Gut. 2022 Jul 12. doi: 10.1136/gutjnl-2022-327209.
5
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer.具核梭杆菌增强结直肠癌中 PD-L1 阻断的疗效。
Signal Transduct Target Ther. 2021 Nov 19;6(1):398. doi: 10.1038/s41392-021-00795-x.
6
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with and Its Subspecies .结直肠癌的分子和病理学特征及其与种系和亚种的关系与患者结局相关。
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):210-220. doi: 10.1158/1055-9965.EPI-21-0463. Epub 2021 Nov 4.
7
Tumour burden and efficacy of immune-checkpoint inhibitors.肿瘤负担与免疫检查点抑制剂的疗效。
Nat Rev Clin Oncol. 2022 Feb;19(2):75-90. doi: 10.1038/s41571-021-00564-3. Epub 2021 Oct 12.
8
Association of mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma.结直肠癌中 突变和 PTEN 缺失与 CD274(PD-L1)表达的关系。
Oncoimmunology. 2021 Aug 2;10(1):1956173. doi: 10.1080/2162402X.2021.1956173. eCollection 2021.
9
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine.结直肠癌的分子亚型:个性化医疗中一个新兴的治疗机会。
Genes Dis. 2019 Oct 30;8(2):133-145. doi: 10.1016/j.gendis.2019.10.013. eCollection 2021 Mar.
10
Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment.结直肠癌的微卫星状态与免疫微环境的关系及其在诊断和治疗中的应用。
J Clin Lab Anal. 2021 Jun;35(6):e23810. doi: 10.1002/jcla.23810. Epub 2021 May 3.